Myron Holubiak
2019
In 2019, Myron Holubiak earned a total compensation of $764.1K as Chief Executive Officer at Citius Pharmaceuticals, a 12% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $204,750 |
|---|---|
| Option Awards | $109,380 |
| Salary | $450,000 |
| Total | $764,130 |
Holubiak received $450K in salary, accounting for 59% of the total pay in 2019.
Holubiak also received $204.8K in non-equity incentive plan and $109.4K in option awards.
Rankings
In 2019, Myron Holubiak's compensation ranked 10,400th out of 13,971 executives tracked by ExecPay. In other words, Holubiak earned more than 25.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,400 out of 13,971 | 26th |
Division Manufacturing | 4,208 out of 5,695 | 26th |
Major group Chemicals And Allied Products | 1,623 out of 2,194 | 26th |
Industry group Drugs | 1,391 out of 1,880 | 26th |
Industry Pharmaceutical Preparations | 1,030 out of 1,392 | 26th |
Source: SEC filing on December 20, 2019.
Holubiak's colleagues
We found two more compensation records of executives who worked with Myron Holubiak at Citius Pharmaceuticals in 2019.
News
Citius Pharmaceuticals CEO Leonard Mazur's 2023 pay jumps 66% to $2M
January 26, 2024
Citius Pharmaceuticals Chairman Myron Holubiak's 2022 pay falls 26% to $1.2M
December 22, 2022
Citius Pharmaceuticals CEO Myron Holubiak's 2021 pay jumps 91% to $1.7M
December 20, 2021
Citius Pharmaceuticals CEO Myron Holubiak's 2020 pay rises 15% to $875K
December 21, 2020
Citius Pharmaceuticals CEO Myron Holubiak's 2019 pay rises 12% to $764K
December 20, 2019
Citius Pharmaceuticals CEO Myron Holubiak's 2018 pay slips 2% to $681K
December 20, 2018